{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:45:01Z","timestamp":1791402301644,"version":"4.3.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T00:00:00Z","timestamp":1439769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/bmt.2015.181","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T16:03:33Z","timestamp":1439222613000},"page":"1465-1472","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis"],"prefix":"10.1038","volume":"50","author":[{"given":"P","family":"Montesinos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rodr\u00edguez-Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Boluda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Mart\u00ednez-Cuadr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lancharro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Arilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"L\u00f3pez-Chuli\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Salavert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pem\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Calvillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Carpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G F","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"BFbmt2015181_CR1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1399-3062.2010.00497.x","volume":"12","author":"P Zhang","year":"2010","unstructured":"Zhang P, Jiang EL, Yang DL, Yan ZS, Huang Y, Wei JL et al. Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single-institution experience. Transpl Infect Dis 2010; 12: 316\u2013321.","journal-title":"Transpl Infect Dis"},{"key":"BFbmt2015181_CR2","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50: 1091\u20131100.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015181_CR3","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1182\/blood-2002-05-1496","volume":"100","author":"KA Marr","year":"2002","unstructured":"Marr KA, Carter RA, Boeckh M, Martin P, Corey L . Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358\u20134366.","journal-title":"Blood"},{"key":"BFbmt2015181_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1086\/591969","volume":"47","author":"C Garcia-Vidal","year":"2008","unstructured":"Garcia-Vidal C, Upton A, Kirby KA, Marr KA . Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008; 47: 1041\u20131050.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015181_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/bmt.2009.39","volume":"44","author":"M Mikulska","year":"2009","unstructured":"Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44: 361\u2013370.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015181_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","volume":"155","author":"DI Marks","year":"2011","unstructured":"Marks DI, Pagliuca A, Kibbler CC, Glasmacher A, Heussel CP, Kantecki M et alIMPROVIT Study Group. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. Br J Haematol 2011; 155: 318\u2013327.","journal-title":"Br J Haematol"},{"key":"BFbmt2015181_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335\u2013347.","journal-title":"N Engl J Med"},{"key":"BFbmt2015181_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","volume":"138","author":"DJ Winston","year":"2003","unstructured":"Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL et al. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. Ann Intern Med 2003; 138: 705\u2013713.","journal-title":"Ann Intern Med"},{"key":"BFbmt2015181_CR9","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","volume":"116","author":"JR Wingard","year":"2010","unstructured":"Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood 2010; 116: 5111\u20135118.","journal-title":"Blood"},{"key":"BFbmt2015181_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1399-3062.2009.00455.x","volume":"12","author":"T Martin","year":"2010","unstructured":"Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M et al. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2010; 12: 45\u201350.","journal-title":"Transpl Infect Dis"},{"key":"BFbmt2015181_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.bmt.1704543","volume":"34","author":"K Thursky","year":"2004","unstructured":"Thursky K, Byrnes G, Grigg A, Szer J, Slavin M . Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 34: 115\u2013121.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015181_CR12","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015181_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BFbmt2015181_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbmt.2009.03.002","volume":"15","author":"P Montesinos","year":"2009","unstructured":"Montesinos P, Sanz J, Cantero S, Lorenzo I, Mart\u00edn G, Saavedra S et al. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biol Blood Marrow Transplant 2009; 15: 730\u2013740.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015181_CR15","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813\u20131821.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015181_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ . A class of K-sample test for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141\u20131154.","journal-title":"Ann Stat"},{"key":"BFbmt2015181_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"J Fine","year":"1999","unstructured":"Fine J, Gray R . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2015181_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/595846","volume":"48","author":"D Neofytos","year":"2009","unstructured":"Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48: 265\u2013273.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015181_CR19","doi-asserted-by":"publisher","first-page":"0939","DOI":"10.1111\/1469-0691.12650","volume":"20","author":"C Garcia-Vidal","year":"2014","unstructured":"Garcia-Vidal C, Royo-Cebrecos C, Peghin M, Moreno A, Ruiz-Camps I, Cervera C et al. Environmental variables associated with an increased risk of invasive aspergillosis. Clin Microbiol Infect 2014; 20: 0939\u20130945.","journal-title":"Clin Microbiol Infect"},{"key":"BFbmt2015181_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2006.01.018","volume":"55","author":"GT Siwek","year":"2006","unstructured":"Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M et al. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis. Diagn Microbiol Infect Dis 2006; 55: 209\u2013212.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"BFbmt2015181_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5144\/1658-3876.2010.167","volume":"3","author":"J El Cheikh","year":"2010","unstructured":"El Cheikh J, Castagna L, Wang L, Esterni B, Faucher C, Furst S et al. Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study. Hematol Oncol Stem Cell Ther 2010; 3: 167\u2013173.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"BFbmt2015181_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1439-0507.1989.tb02299.x","volume":"32","author":"MA Boogaerts","year":"1989","unstructured":"Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beule K . Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 1989; 32: 103\u2013108.","journal-title":"Mycoses"},{"key":"BFbmt2015181_CR23","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1345\/aph.1L243","volume":"42","author":"A Howard","year":"2008","unstructured":"Howard A, Hoffman J, Sheth A . Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis. Ann Pharmacother 2008; 42: 1859\u20131864.","journal-title":"Ann Pharmacother"},{"key":"BFbmt2015181_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/bmt.2013.136","volume":"49","author":"JA Hol","year":"2014","unstructured":"Hol JA, Wolfs TF, Bierings MB, Lindemans CA, Versluys AB, Wildt de A et al. Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients. Bone Marrow Transplant 2014; 49: 95\u2013101.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015181_CR25","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/bmt.2010.38","volume":"45","author":"O Blennow","year":"2010","unstructured":"Blennow O, Remberger M, Klingspor L, Omazic B, Fransson K, Ljungman P et al. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. Bone Marrow Transplant 2010; 45: 1710\u20131718.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015181","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:18:36Z","timestamp":1648059516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFbmt2015181"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.181","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,17]]},"assertion":[{"value":"4 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}